________________________________Ajay K. Banga, Ph.D .:. Home___

Selected Recent Invitations

• • Invited lecture on “Academia Funded Collaborations: Personal Perspectives” presented at the 34^th Annual Meeting of GRASP, Mercer University, College of Pharmacy, Department of Pharmaceutical Sciences,  June 12-14, 2015.

  • Invited lecture on “Getting macromolecules into the skin – what works?”, Nucleic acid delivery devices for HIV vaccines, workshop organized by National Institutes of Health, May 21, 2015, Bethesa, MD.

  •  Invited lecture on “Transdermal devices and patches – enhancement techniques and disposal of residual drug”, presented at Pharma Eds conference on “Transdermal and Intradermal drug delivery systems”, May 11-12, 2015, Philadelphia, PA.

  •  Invited lecture on “Transdermal drug delivery”, B.S. program in Pharmaceutical Sciences, University of Georgia, March 3, 2015, Athens, GA.

  •  “Getting proteins across the skin – what works?”, Biologics Formulation and Delivery Summit, May 5-7, 2014, organized by CHI at 10^th annual PEGS conference, Boston, MA.

  •  “Human skin as an in vitro surrogate model for bioequivalence comparison of topicals”, 2^nd International Conference and Exhibition on Biowaivers and Biosimilars, September 23-25, 2013, Raleigh, NC (also Session Chair).

  •  Invited lecture on “Non-traditional and traditional approaches for delivery into/through skin: What’s new?”, Glaxo Smith Kline, Parsippany, NJ, March 14, 2013. 

  • Microneedles: Pore closure and drug transport, invited speaker/panelist on roundtable on minimally invasive transdermal delivery of biotherapeutics, AAPS National Biotechnology Conference, May 23, 2012, San Diego, CA. 

  • Physical stability challenges for drug-device combination products: Conventional patches and active technology transdermals, invited lecture at the AAPS annual meeting, October 2011, Washington, D.C.

  • Invited lecture on “Transdermal Delivery – The complete picture”, presented at the University of North Carolina School of Pharmacy, October 7, 2011. 

  • Invited lecture on “Physical Enhancement Technologies for Transdermal Delivery of Bioactive Materials”, presented at the 38^th annual meeting of the Controlled Release Society, National Harbor, Maryland, July 30-August 3, 2011.

  • Invited lecture on “New technologies to allow transdermal delivery of biopharmaceuticals,” presented at Pharma Eds conference on “Transdermal drug delivery systems”, Philadelphia, PA, February 24-25, 2011. 

  • Transdermal delivery of biologics, invited lecture and round table discussion at Pfizer, St. Louis, MO, June 21, 2010. 

  • Invited lecture on “New Technologies to Allow Transdermal Delivery of Biopharmaceuticals” and Session Chair for “Drug Delivery” at the 2^nd International Conference on Drug Discovery and Therapy, Dubai, UAE, February 1-4, 2010.

  • Invited lecture on “Pore Closure and Drug Transport in Skin Treated with Maltose Microneedles” in the First International Conference on Microneedles.  Also presented on “Applications of Microneedles” in short course on “Microneedle Design, Fabrication and Evaluation, and co-chaired one session, Georgia Tech, Atlanta May 23-25, 2010.

  • Invited lecture on “Non-traditional technologies to allow Transdermal delivery of hydrophilic molecules and macromolecules”, at the third winter school/workshop on “Nanotechnology in Advanced Drug Delivery” at the National Institute of Pharmaceutical Education and Research, S.A.S. Nagar, India, Feb.8-12, 2010.

  •  Invited keynote speech on “New technologies to allow Transdermal delivery of therapeutic proteins and small water soluble drugs” and Session Chair for Section 3-14, “Recent advances in drug and gene delivery” at the  7^th Annual Congress of International Drug Discovery Science and Technology, Shanghai, China, October 22-25, 2009.

  •  Transdermal Drug Delivery, professional development seminar and lecture in graduate course at Campbell University, NC, Feb. 26, 2009.

  •  Formulation and delivery of protein drugs, all day lecture in drug delivery graduate course at Florida A&M University, Tallahassee, FL, Feb. 3, 2009.

  • Absorption of biologic drugs, invited lecture at the 2007 AAPS National Biotechnology Conference Short Course on “Where did my biologic go – and why ?”, San Diego, CA, June 24, 2007.

  Selected Earlier Invitations

  • New technologies to allow transdermal delivery of therapeutic proteins and small water soluble drugs, invited lecture at University of Nebraska Medical Center, College of Pharmacy Seminar Program.

  • Formulation and delivery of protein drugs, short course presentation to the AAPS Student Chapter, University of Nebraska Medical Center, College of Pharmacy.

  • New enhancement technologies for transdermal delivery of proteins, invited lecture at the Center for Disease Control (CDC).

  • Transdermal delivery of proteins, invited lecture at the International Conference on Bio & Pharmaceutical Science and Technology, The Fine Particle Society, San Diego, CA.

  • Non-traditional transdermal delivery technologies, invited lecture at Penwest, Danbury, CT.

  • New technologies to allow transdermal delivery of therapeutic proteins and small water soluble drugs, invited lecture at Pfizer, Ann Arbor, MI.

  • Transdermal delivery of proteins, invited lecture at the AAPS National Biotechnology Conference, Boston, MA.

  • Iontophoretic drug delivery, invited lecture at Transport Pharmaceuticals, Framingham, MA.

  • Transdermal delivery of proteins, invited lecture at the AAPS annual meeting, Nashville, TN.

  • Formulation and delivery of peptide/protein drugs, invited lecture at National Institute of Technology and Management, Lucknow, India and Matrix Laboratories, Hyderabad, India.

  • Enhancement technologies for transdermal delivery, invited lecture at the Food and Drug Administration, Silver Springs, MD.

  • Enhancement methods for transdermal drug delivery, invited lecture at Georgia Institute of Technology, Atlanta, GA.

  • Protein formulation and delivery, invited lecture at Altea Therapeutics, Atlanta, GA.

  • Approaches to enhanced/modulated drug delivery through skin, invited lecture at Solvay Pharmaceuticals, Marietta, GA.

  • Skin Delivery of Macromolecules, invited lecture at the 53^rd Indian Pharmaceutical Congress and the Center  for Biomedical Engineering at the Indian Institute of Technology in New Delhi, India.

  • Transdermal delivery of macromolecules, invited lecture at the Seminar program of University of Georgia College of Pharmacy, Athens, GA.

  • Organized a short course on "Protein and Gene-based Drugs: Product Development and Delivery Challenges" at the Annual meeting of the American Association of Pharmaceutical Scientists, New Orleans, LA.  Also, gave the opening lecture at this course, "Challenges in the product development  and delivery of protein-based drugs."

  • Electrically-assisted transdermal delivery of peptides, invited lecture at the 19th Annual Meeting of GRASP (Grad. Res. Assoc. Students Pharmaceutics), Holiday Inn, Columbia, SC.

  • Electrically assisted transdermal and topical drug delivery, presentation to the seminar program at the School of Medicine, University of Alabama at Birmingham, AL.

  • Formulation of antimicrobial peptides as gels for Vaginal Use, presentation at Pre-Clinical Topical Microbicides Workshop, National Institute of Allergy and Infectious Diseases, Embassy Suites Hotel Buckhead, Atlanta, GA (invited for presentation by NIH).

  • Characterization and formulation of recombinant proteins, presentation followed by consulting for Procter & Gamble Co., Cincinnati, Ohio.

  • Formulation & Delivery of Therapeutic Peptides and Proteins, presentation given to Eli Lilly & Co. World Headquarters, Indianapolis, IN.

  • Organized (as one of the speakers) a 3-day, 3-speaker seminar on APeptides and Proteins as Parenteral Dosage Forms: Practical Issues in Formulation, Hotel International, Basel, Switzerland.

  • Electrically enhanced transdermal delivery of drugs, presentation given to Empi, Inc., St. Paul, Minnesota.

  • Organized and conducted (as one of the speakers) a 2-day, 2-speaker seminar on AIontophoretic Transdermal Drug Delivery: A New Commercially Feasible Technology, Hotel International, Basel, Switzerland..

  • Formulation and Delivery of Therapeutic Peptides and Proteins, presentation given to Eurand America, Inc., a division of American Home Products, Dayton, Ohio.

  • Organized and conducted (as one of the speakers) a 2-day, 2-speaker seminar on ATherapeutic Peptides and Proteins: Practical Issues in Formulation Development, Hotel International, Basel, Switzerland..

  • Formulation of Therapeutic Proteins, Pharmaceutical Development, Ciba-Geigy World Headquarters, Basel, Switzerland.

  • Formulation and Delivery of Therapeutic Peptides and Proteins, Department of Pharmacy, King=s College London, University of London, London.

  • Transdermal iontophoretic delivery of drugs, Genetronics Inc. (Inovio Biomedical), San Diego, CA.

  • Conducted a Workshop on "Pharmaceutical Issues of Biotechnology Drugs" for the faculty of St. John's University, New York.

  • Product Development of Peptide/Protein drugs, Pharma Development, R&D, Hoechst World Headquarters, Frankfurt, Germany.

  • Transdermal iontophoretic delivery of peptide/protein drugs, Institut fur Pharmazeutische Technologie, der Johann Wolfgang Goethe-Universitat, Frankfurt, Germany.